dexrazoxone

dexrazoxone

Zinecard® Cardiology A bispiperazinedione used to protect against dose-dependent cardiotoxicity by doxorubicin-induced intracellular complexing with iron and formation of O2 free radicals. See Adriamycin.
References in periodicals archive ?
In his positions, he has participated in the early clinical investigations of most of the new agents that have been approved for cancer treatment in the United States over the past 20 years, including gemcitabine, docetaxel, paclitaxel, topotecan, irinotecan, fludarabine, mitoxantrone, and dexrazoxone.